Controversies in radiation for upper rectal cancers.

Area of Science:

• Oncology
• Surgical Oncology
• Gastroenterology

Background:

• Rectal cancer treatment has advanced significantly, requiring multidisciplinary team collaboration.
• Total mesorectal excision (TME) and improved chemoradiation have reduced locoregional recurrence.
• Preoperative chemoradiation is beneficial for most transmural and/or node-positive rectal cancers.

Purpose of the Study:

• To evaluate the uniform application of preoperative chemoradiation for all rectal cancer patients.
• To determine the optimal treatment strategy based on rectal tumor location.
• To assess the benefit of upfront surgery versus preoperative chemoradiation for upper rectal tumors.

Main Methods:

• Review of large randomized studies on rectal cancer treatment.
• Analysis of outcomes based on tumor location (high vs. lower rectum).
• Evaluation of the role of total mesorectal excision (TME) and preoperative chemoradiation.

Main Results:

• Preoperative chemoradiation shows significant benefit for most rectal cancer patients.
• For high rectal tumors, the risk of local recurrence is lower, and sphincter preservation is not a factor.
• Upfront surgery for upper rectal tumors allows for more accurate pathologic staging.

Conclusions:

• A uniform approach to preoperative chemoradiation for all rectal cancer locations is not recommended.
• Upfront surgery is advised for upper rectal tumors (T3,N0,M0) to guide subsequent treatment decisions.
• The addition of chemoradiation offers minimal benefit for upper rectal tumors after TME with adequate node retrieval.